• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Gene Watch - Product Image

Gene Watch

  • ID: 1820999
  • November 2014
  • Region: Global
  • Council for Responsible Genetics

FEATURED COMPANIES

  • 23andMe
  • GlaxoSmithKline
  • Monsanto
  • Myriad Genetics
  • Navigenics
  • MORE

GeneWatch is America's first and only magazine dedicated to monitoring biotechnology's social, ethical and environmental consequences. Since 1983, GeneWatch has covered a broad spectrum of issues, from genetically engineered foods to biological weapons, genetic privacy and discrimination, reproductive technologies, and human cloning.

While the field of biotechnology holds the potential for dramatic progress in the future, it is also full of misinformation and exaggerated claims. Indeed, biotechnology presents profound national and global policy concerns as well; including the potential impact of scientific developments on human rights and public health. Now, more than ever, there is the need for a strong, independent watchdog.

Countries covered include: the United Kingdom, Canada, countries within the EU, Australia & India.

This GeneWatch subscription provides 5 to 6 magazines annually.

FEATURED COMPANIES

  • 23andMe
  • GlaxoSmithKline
  • Monsanto
  • Myriad Genetics
  • Navigenics
  • MORE

Volume 24 Issue 1: Biobanks; Feb-Mar 2011

Time to Raise Some Hell By Henry T. Greely

Suspect Creatures By CRG staff - with George Annas, Robert Green, Patricia Roche and Susan Wolf

The Harm of Hype By CRG staff - interview with James Evans

UK Biobank: The Grand Experiment By Helen Wallace

From the Cradle to the Lab By Samuel W. Anderson

Book Review: Ethical Issues of Human Genetic Databases By Andrew D. Thibedeau

Case in Point: The NIH’s Biobank Breach By CRG Staff

Genetic Privacy Worries on the Rise By CRG staff - interview with Christy White, Cogent Research

Re-lighting the Beacon By Steve May

GM Alfalfa: An Uncalculated Risk By Philip Bereano

Topic Update: Direct-to-Consumer Genetic Testing Criticized at FDA Hearing By CRG Staff

Editorial By Samuel W. Anderson

FEATURED COMPANIES

  • 23andMe
  • GlaxoSmithKline
  • Monsanto
  • Myriad Genetics
  • Navigenics
  • MORE

Since 1983, the Council for Responsible Genetics (CRG) has represented the public interest and fostered public debate about the social, ethical and environmental implications of genetic technologies. It is the only biotech public interest organization that is explicitly dedicated to examining the best science, interpreting the results, assessing the implications, communicating them to a general audience and facilitating meaningful, measurable change.

CRG continues to carry out these functions through the creation of coalitions of scholars and advocates; translation of scientific and policy analyses into clear and accessible terms for the public, social justice advocates, legislators and the media; and by providing an international, science based source of credible, trusted, current and reliable information on the impacts and implications of developments in biotechnology. Its staff and Board members regularly assist policy makers and have testified before Congress, Federal agencies, regulatory bodies and state legislatures.

The Council for Responsible Genetics is a leader in the movement to steer biotechnology toward the advancement of public health, environmental protection, equal justice, and respect for human rights through lasting policy reform in the United States and around the world.

- GlaxoSmithKline
- 23andMe
- Navigenics
- Myriad Genetics
- Monsanto

Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Biotech Business - Product Thumbnail Image Biotech Business

    Biotech Business

    • Language: English
    • Published: November 2014
    • Region: Global
    FROM
  • Biotech Financial Reports - Product Thumbnail Image Biotech Financial Reports

    Biotech Financial Reports

    • Language: English
    • Published: November 2014
    • Region: Global
    FROM
  • Deals in Europe Online Data Service - Product Thumbnail Image Deals in Europe Online Data Service

    Deals in Europe Online Data Service

    • Language: English
    • Published: November 2014
    • Region: Europe
  • Endometriosis News. Direct! Journal - Product Thumbnail Image Endometriosis News. Direct! Journal

    Endometriosis News. Direct! Journal

    • Language: English
    • 36 Pages
    • Published: November 2014
    • Region: India
  • Pathogens and Global Health - Product Thumbnail Image

    Pathogens and Global Health

    • Language: English
    • Published: November 2014
    • Region: Global
    FROM
  • Personalized Medicine - Scientific and Commercial Aspects - Product Thumbnail Image Personalized Medicine - Scientific and Commercial Aspects

    Personalized Medicine - Scientific and Commercial Aspects

    • Language: English
    • 939 Pages
    • Published: November 2014
    • Region: Global
    FROM
  • Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image Gene Therapy - Technologies, Markets and Companies

    Gene Therapy - Technologies, Markets and Companies

    • Language: English
    • 678 Pages
    • Published: November 2014
    • Region: Global
    FROM
  • DNA Sequencing - Technologies, Markets and Companies - Product Thumbnail Image DNA Sequencing - Technologies, Markets and Companies

    DNA Sequencing - Technologies, Markets and Companies

    • Language: English
    • 450 Pages
    • Published: November 2014
    • Region: Global
    FROM
  • Genetic Engineering - Global Outlook - Product Thumbnail Image Genetic Engineering - Global Outlook

    Genetic Engineering - Global Outlook

    • Language: English
    • 118 Pages
    • Published: January 2012
    • Region: Global
    FROM
  • Biobanks - 2012 Year Book - Product Thumbnail Image

    Biobanks - 2012 Year Book

    • Language: English
    • 69 Pages
    • Published: July 2012
    FROM

Our Clients

Our clients' logos